Bank of New York Mellon’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bank of New York Mellon’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-680,307	Closed	-$118M	–	4410
2015 Q1	$118M	Sell	680,307 -15,958	-2%	-$2.34M	0.03%	538
2014 Q4	$80M	Sell	696,265 -264,249	-28%	-$32M	0.02%	672
2014 Q3	$150M	Sell	960,514 -989,876	-51%	-$144M	0.04%	441
2014 Q2	$241M	Sell	1,950,390 -349,687	-15%	-$38.7M	0.06%	319
2014 Q1	$238M	Sell	2,300,077 -929,725	-29%	-$95.2M	0.06%	310
2013 Q4	$290M	Sell	3,229,802 -339,654	-10%	-$27.1M	0.08%	258
2013 Q3	$239M	Buy	3,569,456 +197,488	+6%	+$13.6M	0.07%	292
2013 Q2	$223M	Buy	+3,371,968	New	+$193M	0.07%	290

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Bank of New York Mellon's SLXP Position: Q2 2015 in Review

Bank of New York Mellon sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 680,307 shares — an estimated $118M sold.

Bank of New York Mellon first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $290M in Q4 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Bank of New York Mellon reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Bank of New York Mellon sold 680,307 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $118M.
Bank of New York Mellon first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Bank of New York Mellon's SALIX PHARMACEUTICALS LTD DEL position peaked at $290M in Q4 2013.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Bank of New York Mellon's 13F filing for Q2 2015, filed 6 Aug 2015.